Paid Sick Leave, Care Delays, and Mortality Risk in Working Cancer Survivors
JCO Oncology Practice · 10.06.2026
DOI: 10.1200/op-26-00261 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, online erschienen am 10.06.2026. Verfasst von Abigail Kohut-Jackson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Saint Louis University School of Medicine, St Louis, MO. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Cancer survivors endure costly and time-intensive care throughout treatment and survivorship. Paid sick leave provides employment and financial stability while supporting time off for medical needs. We investigated whether paid sick leave is associated with financial hardship and overall and cancer-specific mortality risk in working adult cancer survivors. METHODS Working adults age 18-64 years with a cancer history were identified from the National Health Interview Survey (NHIS) between 2011 and 2023. Associations of paid sick leave and financial hardship (medical care delays, problems paying medical bills, worry about paying medical bills, and cost-related medication underuse) were examined with 2011-2018 and 2019-2023 data using separate multivariable logistic regressions because of survey redesign in 2019. Linked mortality files from the National Death Index were available for 2011-2018 respondents. The association of paid sick leave and mortality risk was examined with multivariable Cox proportional hazards models. RESULTS A total of 8,091 and 3,919 working cancer survivors were identified from the 2011-2018 and 2019-2023 NHIS, respectively. Paid sick leave was associated with decreased medical care delays because of cost (2011-2018 odds ratio [OR], 0.74 [95% CI, 0.60 to 0.93]; P = .008; 2019-2023 OR, 0.51 [95% CI, 0.35 to 0.74]; P < .001) but not consistently with other forms of financial hardship. In adjusted analyses, paid sick leave was associated with significant reductions in risk of overall mortality (hazard ratio [HR], 0.74 [95% CI, 0.61 to 0.9]; P = .003) and cancer mortality (HR, 0.74 [95% CI, 0.61 to 0.91]; P = .003). CONCLUSION In working cancer survivors, paid sick leave is associated with decreased care delays and lower overall and cancer-specific mortality risk, which may be due to maintained employment, household income, and health insurance coverage leading to improvements in treatment access, affordability, and overall survivorship care.
Autor:innen und Institutionen
- Saint Louis University School of Medicine, St Louis, MO.
- Division of Radiation Oncology, MD Anderson Cancer Center, Houston, TX.
- Department of Surveillance, Prevention and Health Services Research, American Cancer Society, Atlanta, GA.
- Brown School, Washington University in St Louis, St Louis, MO.
- School of Public Health, Washington University in St Louis, St Louis, MO.
- General Medical Sciences Division, Department of Medicine, Washington University School of Medicine, St Louis, MO.
ORCID-Profile: Abigail Kohut-Jackson, Fumiko Chino, Zhiyuan Zheng, Xuesong Han, Kimberly J Johnson, K Robin Yabroff, Kenton Johnston, Justin M Barnes
Zitieren
APA
Kohut-Jackson, A., Chino, F., Zheng, Z., Han, X., Johnson, K. J., Yabroff, K. R., Johnston, K., & Barnes, J. M. (2026). Paid Sick Leave, Care Delays, and Mortality Risk in Working Cancer Survivors. JCO Oncology Practice. https://doi.org/10.1200/op-26-00261
Vancouver
Kohut-Jackson A, Chino F, Zheng Z, Han X, Johnson KJ, Yabroff KR, et al. Paid Sick Leave, Care Delays, and Mortality Risk in Working Cancer Survivors. JCO Oncology Practice. 2026. doi:10.1200/op-26-00261
BibTeX
@article{KohutJackson2026,
author = {Kohut-Jackson, Abigail and Chino, Fumiko and Zheng, Zhiyuan and Han, Xuesong and Johnson, Kimberly J and Yabroff, K Robin and Johnston, Kenton and Barnes, Justin M},
title = {Paid Sick Leave, Care Delays, and Mortality Risk in Working Cancer Survivors},
journal = {JCO Oncology Practice},
year = {2026},
doi = {10.1200/op-26-00261}
}
EUVIMED